|
MFN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.79536418854332E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8934853684982E-12 |
| Normal-vs-Stage2 |
1.69169999997276E-06 |
| Normal-vs-Stage3 |
2.09350000002217E-07 |
| Normal-vs-Stage4 |
1.33130000357085E-08 |
| Stage1-vs-Stage2 |
5.236800E-01 |
| Stage1-vs-Stage3 |
6.411000E-01 |
| Stage1-vs-Stage4 |
3.102600E-01 |
| Stage2-vs-Stage3 |
8.426200E-01 |
| Stage2-vs-Stage4 |
6.002600E-01 |
| Stage3-vs-Stage4 |
4.931800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63902225125412E-12 |
| Normal-vs-AfricanAmerican |
2.07079997593951E-09 |
| Normal-vs-Asian |
2.6842000000471E-06 |
| Caucasian-vs-AfricanAmerican |
4.344800E-01 |
| Caucasian-vs-Asian |
5.412800E-01 |
| AfricanAmerican-vs-Asian |
4.020800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.13242748511766E-14 |
| Normal-vs-Female |
2.28159999782207E-08 |
| Male-vs-Female |
1.876840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.54099996599422E-09 |
| Normal-vs-Extreme_Weight |
3.99680288865056E-15 |
| Normal-vs-Obese |
4.71500616328058E-12 |
| Normal-vs-Extreme_Obese |
8.036200E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.972600E-01 |
| Normal_Weight-vs-Obese |
6.210200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.626600E-01 |
| Extreme_Weight-vs-Obese |
3.422000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.843600E-01 |
| Obese-vs-Extreme_Obese |
4.407600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.497100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.68931535426964E-12 |
| Normal-vs-Age(61-80Yrs) |
1.76270109619736E-12 |
| Normal-vs-Age(81-100Yrs) |
6.51579999955132E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.734200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.648400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.291200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.146400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.277400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.491000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.99680288865056E-15 |
| Normal-VS-Type2 PRCC |
1.52409999953917E-07 |
| Normal-VS-KIRP CIMP |
8.77429999768253E-08 |
| Normal-VS-Unclassified PRCC |
1.206120E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.455430E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.036600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.023980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.693200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.056600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.545600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.5851000512157E-09 |
| Normal-vs-N1 |
4.40825154157665E-12 |
| Normal-vs-N2 |
2.2236999999925E-05 |
| N0-vs-N1 |
1.990450E-01 |
| N0-vs-N2 |
5.604000E-01 |
| N1-vs-N2 |
9.883200E-01 |
|
|
